β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Exclusion Criteria

• •History of hypersensitivity or intolerance to echinocandin antifungals
• •Liver function test (ALT, AST (aspartate aminotransferase), and/or total bilirubin) greater than 10 times the upper limits of normal (ULN)
• •Pregnant or lactating women
• •Treatment with systemic antifungal therapy within the preceding 7 days
• •Documented invasive fungal infection at baseline/screening
• •Life expectancy less than 2 days or moribund